Vor Bio to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Morgan Stanley 20th Annual Global Healthcare Conference
Fireside Chat: Monday, September 12, 2022 at 4:50 pm ET
Location: Sheraton Hotel, New York, NY
H.C. Wainwright 24th Annual Global Investment Conference (Hybrid)
Fireside chat: Wednesday, September 14, 2022 at 8:30 am ET
Location: Lotte New York Palace Hotel, New York, NY
Baird’s 2022 Global Healthcare Conference
Fireside chat: Wednesday, September 14, 2022 at 10:50 am ET
Location: Intercontinental New York Barclay, New York, NY
Jefferies Cell and Genetic Medicine Summit
Fireside chat: Friday, September 30, 2022
Location: Lotte New York Palace Hotel, New York, NY
A live webcast and archived replay of the fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference will be available on the investors section of .
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: .
Contact:
Media & Investors
Sarah Spencer
